Biodegradable Polymeric Prodrugs

可生物降解的聚合物前药

• 批准号: 6968133
• 负责人: KATHRYN Elizabeth UHRICH
• 金额: $ 31.95万
• 依托单位: RUTGERS, THE STATE UNIV OF N.J.
• 依托单位国家: 美国
• 财政年份: 2000
• 资助国家: 美国
• 起止时间: 2000-08-01 至 2010-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6968133
• 关键词: biodegradable product; biomaterial development /preparation; biomaterial evaluation; dental agent; drug delivery systems; hydrolysis; inflammation; laboratory rat; nonsteroidal antiinflammatory agent; periodontium; periodontium disorder; polymers; prodrugs; salicylate; slow release drug

DESCRIPTION (provided by applicant): Periodontal diseases comprise a group of related microbial-induced chronic inflammatory disorders that destroy the tissue supporting the teeth. The goals of this project are: to accelerate the recovery/restoration of new, healthy periodontal architecture by reducing inflammation; to reduce post-operative pain after periodontal surgery; and to create an unfavorable environment for periodontic bacteria. These goals are achieved using biodegradable (bioresorbable) polymers in which the polymer itself is a controlled-release system: the polymer serves as a temporary barrier that degrades into therapeutically active molecules such as non-steroidal anti-inflammatory drugs (NSAIDs) and concurrently releases admixed antimicrobials. We build upon our previous research with salicylate-based polymers, creating new NSAID-based polymers to simultaneously reduce inflammation, control pain, and eliminate bacteria while providing a biodegradable scaffold for restoring periodontal tissues. As a function of in vivo polymer degradation, we present the following questions: 1. Can NSAIDs be incorporated into a polymer backbone, such that hydrolytic degradation of the polymer directly releases the NSAID? 2. Does the localized release of NSAID promote localized bone growth? 3. Can antimicrobials that are physically admixed within the NSAID-based polymers be released concurrent to the chemically incorporated NSAID? 4. Will the combination of physically admixed antimicrobials and polymer degradation-dependent release of NSAID promote bone growth even further? The overall objective of this proposal is to determine if the local delivery of NSAIDs via degradable polymers will simultaneously reduce inflammation, eliminate bacteria and restore healthy periodontal architecture.

描述（由申请人提供）：牙周病包括一组相关的微生物引起的慢性炎症性疾病，这些疾病会破坏支撑牙齿的组织。该项目的目标是：通过减少炎症加速新的、健康的牙周结构的恢复/恢复；减轻牙周手术后疼痛；并为牙周细菌创造一个不利的环境。这些目标是通过使用可生物降解（生物可吸收）聚合物来实现的，其中聚合物本身是一个控释系统：聚合物作为一个临时屏障，降解成治疗活性分子，如非甾体抗炎药（NSAIDs），同时释放混合抗菌剂。我们在之前研究水杨酸基聚合物的基础上，创造了新的基于非甾体抗炎药的聚合物，同时减少炎症，控制疼痛，消除细菌，同时为修复牙周组织提供可生物降解的支架。作为体内聚合物降解的功能，我们提出以下问题：1。非甾体抗炎药能否掺入聚合物骨架中，使聚合物水解降解直接释放非甾体抗炎药？2. 非甾体抗炎药的局部释放是否促进局部骨生长？3. 物理混合在非甾体抗炎药聚合物中的抗菌剂能否与化学掺入的非甾体抗炎药同时释放？4. 物理混合抗菌剂和非甾体抗炎药聚合物降解依赖性释放的组合是否会进一步促进骨生长？本提案的总体目标是确定通过可降解聚合物局部递送非甾体抗炎药是否会同时减少炎症、消除细菌和恢复健康的牙周结构。